Basic ScienceCurcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport

Add time:08/26/2019    Source:sciencedirect.com

BackgroundAdipocyte dysfunction, obesity and associated metabolic disorders are of prime healthcare concern worldwide. Among available medications, natural products and inspired molecules hold 40% space in clinically prescribed medicines. In queue, this study overcomes the drawback of curcumin's low bioavailability with potent anti-adipogenic and anti-dyslipidemic activity.

We also recommend Trading Suppliers and Manufacturers of 4-(3,4-DICHLORO-PHENYL)-1H-IMIDAZOLE (cas 13608-74-7). Pls Click Website Link as below: cas 13608-74-7 suppliers

Prev:3-(4-Piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as ligands for the ORL-1 receptor
Next:Air oxidation of 17-hydroxycorticosteroids catalyzed by cupric acetate: formation of hemiacetal dimers)